Table 5.
Characteristics | Survivor, N (%) | Non-survivor, N (%) | p-value | OR | 95% CI |
---|---|---|---|---|---|
113 (76.4%) | 35 (23.6%) | ||||
Age, years (mean, range) | 55 (20, 85) | 79 (39–93) | <0.001 | ||
Comorbidity (no/yes), N (%) | 33/79 (29.46/70.53%) | 0/34 (0/100%) | <0.001 | 29.075 | [1.73, 488.24] |
Hemoglobin, g/dL | 13.8 (7.9, 17.8) | 12.6 (5.7, 16.6) | 0.013 | ||
Neutrophils, /μL | 4.18 (1.1, 18.1) | 8.13 (2.8, 23.4) | <0.001 | ||
Lymphocytes, /μL | 1.6 (0.4, 9.8) | 1.05 (0.3, 2.8) | <0.001 | ||
CRP, mg/L | 7.53 (0.2, 343.1) | 88.11 (0.4, 279.2) | <0.001 | ||
Ferritin, μg/L | 251.5 (12.9, 3,115) | 703.5 (59.2, 10,538) | <0.001 | ||
Fibrinogen, mg/dL | 398 (115, 907) | 490 (117, 807) | 0.002 | ||
D-dimer, μg/ml FEU | 0.5 (0, 21) | 1.81 (0.3, 21) | <0.001 | ||
PT, s | 14 (11.3, 50.9) | 16.2 (12.6, 43.3) | <0.001 | ||
aPTT, s | 28.9 (7.1, 53.5) | 32.1 (22.7, 48.9) | 0.004 | ||
AST, U/L | 22.2 (11.2, 145.9) | 33 (8.7, 107.8) | 0.005 | ||
BUN, mg/dL | 32.3 (0.6, 102.9) | 51.1 (18.1, 139.1) | <0.001 |
OR values and 95% confidence interval (CI) were presented only for significant associations.